178 related articles for article (PubMed ID: 33369742)
1. Clinicopathological analysis of primary cutaneous CD4-positive small/medium pleomorphic T-cell lymphoproliferative disorder: a retrospective study of 22 patients.
Shi HZ; Zhang J; Xiong JS; Gan L; Jiang YQ; Xu XL; Zhang W; Zeng XS; Sun JF; Chen H
Int J Dermatol; 2021 Apr; 60(4):497-502. PubMed ID: 33369742
[TBL] [Abstract][Full Text] [Related]
2. CD30+ T cell enriched primary cutaneous CD4+ small/medium sized pleomorphic T cell lymphoma: A distinct variant of indolent CD4+ T cell lymphoproliferative disease.
Magro CM; Olson LC; Fulmer CG
Ann Diagn Pathol; 2017 Oct; 30():52-58. PubMed ID: 28965629
[TBL] [Abstract][Full Text] [Related]
3. The Clinical Spectrum of Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoproliferative Disorder: An Updated Systematic Literature Review and Case Series.
Surmanowicz P; Doherty S; Sivanand A; Parvinnejad N; Deschenes J; Schneider M; Hardin J; Gniadecki R
Dermatology; 2021; 237(4):618-628. PubMed ID: 33326960
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder-clinical and histopathologic features, differential diagnosis, and treatment.
Gru AA; Wick MR; Eid M
Semin Cutan Med Surg; 2018 Mar; 37(1):39-48. PubMed ID: 29719019
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up and management of small and medium-sized CD4
Virmani P; Jawed S; Myskowski PL; Horwitz S; Skripnik Lucas A; Moskowitz A; Pulitzer M; Zain J; Rosen ST; Querfeld C
Int J Dermatol; 2016 Nov; 55(11):1248-1254. PubMed ID: 27369070
[TBL] [Abstract][Full Text] [Related]
6. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma.
Cetinözman F; Jansen PM; Willemze R
Am J Surg Pathol; 2012 Jan; 36(1):109-16. PubMed ID: 21989349
[TBL] [Abstract][Full Text] [Related]
7. Acneiform primary cutaneous CD4-positive small/medium pleomorphic T-cell lymphoma with prominent necrosis.
Wang L; Wang G; Gao T
J Cutan Pathol; 2015 Apr; 42(4):265-70. PubMed ID: 25407448
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of follicular T-helper cells in primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoma and dermatitis.
Ally MS; Prasad Hunasehally RY; Rodriguez-Justo M; Martin B; Verdolini R; Attard N; Child F; Attygalle A; Whittaker S; Morris S; Robson A
J Cutan Pathol; 2013 Dec; 40(12):1006-13. PubMed ID: 24274425
[TBL] [Abstract][Full Text] [Related]
9. Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders: A Clinical, Pathologic, and Molecular Study of 60 Cases Presenting With a Single Lesion: A Multicenter Study of the French Cutaneous Lymphoma Study Group.
Beltzung F; Ortonne N; Pelletier L; Beylot-Barry M; Ingen-Housz-Oro S; Franck F; Pereira B; Godfraind C; Delfau MH; D'Incan M; Vergier B
Am J Surg Pathol; 2020 Jul; 44(7):862-872. PubMed ID: 32271188
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and molecular study of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma.
Alberti-Violetti S; Torres-Cabala CA; Talpur R; Corti L; Fanoni D; Venegoni L; Berti E; Duvic M
J Cutan Pathol; 2016 Dec; 43(12):1121-1130. PubMed ID: 27550169
[TBL] [Abstract][Full Text] [Related]
11. Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder or Primary Cutaneous Marginal Zone B-Cell Lymphoma? Two Distinct Entities With Overlapping Histopathological Features.
Bakr F; Wain EM; Barlow R; Robson A
Am J Dermatopathol; 2021 Dec; 43(12):e204-e212. PubMed ID: 34231494
[TBL] [Abstract][Full Text] [Related]
12. Differential NFATc1 Expression in Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoma and Other Forms of Cutaneous T-Cell Lymphoma and Pseudolymphoma.
Magro CM; Momtahen S
Am J Dermatopathol; 2017 Feb; 39(2):95-103. PubMed ID: 27097342
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous CD4 positive small/medium T-cell lymphoma with high proliferation index and CD30-positive large lymphoid cells.
Zhang L; Shao H
J Cutan Pathol; 2013 Aug; 40(8):720-4. PubMed ID: 23672694
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathological features of indolent T-cell lymphoproliferative disorder of the gastrointestinal tract: a report of five cases].
Shao SH; Gu HY; Lin DL; Shi HL; Zhang YJ; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):762-766. PubMed ID: 31594039
[No Abstract] [Full Text] [Related]
15. Primary Cutaneous CD4
Maurelli M; Colato C; Gisondi P; Girolomoni G
J Cutan Med Surg; 2017; 21(6):502-506. PubMed ID: 28605998
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous CD4+ small-/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases.
Beltraminelli H; Leinweber B; Kerl H; Cerroni L
Am J Dermatopathol; 2009 Jun; 31(4):317-22. PubMed ID: 19461234
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous small- to medium-sized CD4+ pleomorphic T-cell lymphoma: a retrospective case series and review of the provisional cutaneous lymphoma category.
Williams VL; Torres-Cabala CA; Duvic M
Am J Clin Dermatol; 2011 Dec; 12(6):389-401. PubMed ID: 21863906
[TBL] [Abstract][Full Text] [Related]
18. Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype.
Kummer JA; Vermeer MH; Dukers D; Meijer CJ; Willemze R
J Invest Dermatol; 1997 Nov; 109(5):636-40. PubMed ID: 9347791
[TBL] [Abstract][Full Text] [Related]
19. Surgical, Dermatological and Morphopathological Considerations in the Diagnosis and Treatment of Cutaneous Lymphoproliferative Tumors, Primary CD4.
Ardeleanu V; Moroianu LA; Sava A; Tebeica T; Jecan RC; Moroianu M; Tatu AL
Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363575
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous Small/Medium CD4+ Pleomorphic T-Cell Lymphoma-Like Nodule in a Patient With Erythema Chronicum Migrans.
Celebi Cherukuri N; Roth CG; Aggarwal N; Ho J; Gehris R; Akilov OE
Am J Dermatopathol; 2016 Jun; 38(6):448-52. PubMed ID: 27097344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]